KLF8 is a member of the KLF
transcription factor family that plays an important role in
oncogenesis. However, the role of KLF8 in
colorectal cancer remains unknown. The aims of the present study were to examine KLF8 expression in
colorectal cancers, to determine the role of KLF8 in cell differentiation and to investigate the antiproliferative effect of KLF8 silencing. The expression of KLF8 and phospho-ERK
proteins was analyzed, and the effects of KLF8 suppression on cell differentiation and growth were evaluated. In addition, the
biological impact of KLF8 knockdown on
colorectal cancer cells was investigated in vitro and in vivo. The expression of the KLF8
protein was higher in 10/14 (71.43%) fresh
cancer tissues compared with adjacent normal tissues, and the blockade of ERK signaling by
U0126 decreased the expression of KLF8 in a time- and dose-dependent manner. Furthermore, KLF8-siRNA induced the expression of
carcinoembryonic antigen (CEA) and
E-cadherin as well as the maturation of
F-actin. KLF8 suppression inhibited serum-dependent, anchorage‑dependent and -independent cell growth. Moreover, KLF8 silencing induced apoptosis and sensitized
cancer cells to
5-fluorouracil (5-FU). A strong antitumorigenic effect by lenti-KLF8-shRNA, which was enhanced when combined with
5-FU treatment, was exerted in nude mice. Thus, KLF8 suppression induced cell differentiation and inhibited
tumorigenesis.